Published in J Cell Physiol on May 01, 1988
Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci U S A (1990) 2.09
Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J Cell Biol (1993) 1.33
Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J Cell Biol (1994) 1.15
Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol (1994) 0.99
Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc Natl Acad Sci U S A (1991) 0.94
Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals. J Neurochem (2006) 0.91
Exogenous glycosaminoglycans induce complete inversion of retinal ganglion cell bodies and their axons within the retinal neuroepithelium. Proc Natl Acad Sci U S A (1994) 0.88
Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest (1994) 0.80
Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci (1994) 10.46
Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci U S A (1986) 10.41
Blood vessel formation: what is its molecular basis? Cell (1996) 5.54
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33
Pericytes in the microvasculature. Cardiovasc Res (1996) 3.95
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol (1987) 3.72
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A (1989) 3.65
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A (1999) 3.54
Regulators of angiogenesis. Annu Rev Physiol (1991) 3.27
The dynamin-related GTPase, Mgm1p, is an intermembrane space protein required for maintenance of fusion competent mitochondria. J Cell Biol (2000) 3.14
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95
Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol (1985) 2.91
Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res (1999) 2.79
Purification of synaptic vesicles from elasmobranch electric organ and the use of biophysical criteria to demonstrate purity. Biochemistry (1978) 2.62
The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem (1996) 2.58
Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol (2003) 2.57
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun (1993) 2.56
Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn (2001) 2.53
Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects. Clin Pharmacol Ther (2007) 2.53
Vascular development: cellular and molecular regulation. FASEB J (1997) 2.35
Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett (1995) 2.31
The value, qualification, and regulatory use of surrogate end points in drug development. Clin Pharmacol Ther (2009) 2.08
Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J (1994) 2.06
Detection of hepatitis A antigen by immunofluorescence. Infect Immun (1977) 2.00
Angiogenic activity from bovine retina: partial purification and characterization. Proc Natl Acad Sci U S A (1981) 1.94
Growth factors are released by mechanically wounded endothelial cells. J Cell Biol (1989) 1.92
Chemical and physical characterization of cholinergic synaptic vesicles. Biochemistry (1978) 1.90
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J (1998) 1.89
Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol (1980) 1.87
Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA. Proc Natl Acad Sci U S A (1986) 1.85
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med (2001) 1.80
The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clin Pharmacol Ther (2008) 1.80
Biochemistry of neurotransmitter release. Annu Rev Neurosci (1979) 1.78
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev (1996) 1.75
Blood vessel maturation: vascular development comes of age. J Clin Invest (1999) 1.70
THE INTRAVENOUS USE OF SERUM AND PLASMA, FRESH AND PRESERVED. Ann Surg (1940) 1.70
Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities. J Cell Biol (1984) 1.69
Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer (1995) 1.69
Mechanisms of angiogenesis. Annu Rev Physiol (1987) 1.68
Culture of retinal capillary cells using selective growth media. Microvasc Res (1983) 1.67
Wnt signaling in the vasculature. Angiogenesis (2002) 1.62
Clonal variants of PC12 pheochromocytoma cells with defects in cAMP-dependent protein kinases induce ornithine decarboxylase in response to nerve growth factor but not to adenosine agonists. Mol Cell Biol (1985) 1.57
TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis (2001) 1.56
Cell-cell interactions in vascular development. Curr Top Dev Biol (2001) 1.48
Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet (1998) 1.48
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin. Clin Pharmacol Ther (2007) 1.48
Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS (1997) 1.46
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem (1999) 1.42
What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci (2007) 1.42
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther (2007) 1.39
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. Clin Pharmacol Ther (2008) 1.38
Characterization of vascular development in the mouse retina. Microvasc Res (1988) 1.37
Topological organization of proteins in an intracellular secretory organelle: the synaptic vesicle. Proc Natl Acad Sci U S A (1979) 1.37
Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin Pharmacol Ther (2007) 1.33
Endocannabinoids as cardiovascular modulators. Chem Phys Lipids (2000) 1.31
Adult tissues contain chemoattractants for vascular endothelial cells. Nature (1980) 1.30
Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res (1999) 1.30
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30
Age and temperature regulation of humans in neutral and cold environments. J Appl Physiol (1974) 1.28
Regulation of Cl- channels by multifunctional CaM kinase. Neuron (1991) 1.28
Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. J Infect Dis (1978) 1.26
Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther (2009) 1.24
Thermoregulatory responses during competitive marathon running. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.23
Nerve growth factor action is mediated by cyclic AMP- and Ca+2/phospholipid-dependent protein kinases. J Cell Biol (1986) 1.23
Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms. Clin Pharmacol Ther (2009) 1.21
HES-1 repression of differentiation and proliferation in PC12 cells: role for the helix 3-helix 4 domain in transcription repression. Mol Cell Biol (2000) 1.21
Induction of immediate early genes by Ca2+ influx requires cAMP-dependent protein kinase in PC12 cells. J Biol Chem (1991) 1.15
Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design. Clin Pharmacol Ther (2010) 1.14
Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies. Clin Pharmacol Ther (2009) 1.14
Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities. J Biol Chem (1991) 1.13
Rac is required for growth cone function but not neurite assembly. J Cell Sci (1997) 1.12
Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci U S A (1992) 1.11
Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life. J Cell Physiol (1989) 1.11
Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci (1996) 1.11
Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J Cell Biochem (1995) 1.09
Nerve growth factor and fibroblast growth factor regulate neurite outgrowth and gene expression in PC12 cells via both protein kinase C- and cAMP-independent mechanisms. J Cell Biol (1990) 1.07
A transformed human epithelial cell line that retains tight junctions post crisis. In Vitro Cell Dev Biol (1993) 1.07
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension (2000) 1.06
Endothelial cell regulation by transforming growth factor-beta. J Cell Biochem (1991) 1.04
Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. J Biol Chem (1989) 1.03
Acidic fibroblast growth factor enhances regeneration of processes by postnatal mammalian retinal ganglion cells in culture. Proc Natl Acad Sci U S A (1988) 1.03
Nerve growth factor regulates gene expression by several distinct mechanisms. Mol Cell Biol (1989) 1.03
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval. J Clin Pharmacol (2008) 1.02
Functional and biochemical interactions of Wnts with FrzA, a secreted Wnt antagonist. Development (1998) 1.02
Src, ras, and rac mediate the migratory response elicited by NGF and PMA in PC12 cells. J Neurosci Res (1996) 1.01
Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol (1994) 1.00
Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta. J Cell Sci (1994) 1.00
Systemic scleroderma with complete heart block. Report of a case with comprehensive study of the conduction system. Am Heart J (1966) 0.99
Influences of age and gender on human thermoregulatory responses to cold exposures. J Appl Physiol (1985) (1985) 0.99
Localization of hepatitis A antigen in liver tissue by peroxidase-conjugated antibody method: light and electron microscopic studies. J Immunol (1978) 0.99
Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci (1991) 0.98
Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction. Clin Pharmacol Ther (2011) 0.98
The activity of cAMP-dependent protein kinase is required at a posttranslational level for induction of voltage-dependent sodium channels by peptide growth factors in PC12 cells. J Cell Biol (1992) 0.97
Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm. J Clin Pharmacol (2009) 0.96